Meeting Details - The sixth board meeting of Jiangsu Baoxin Technology Co., Ltd. was held on September 3, 2025, via electronic mail notification, with all directors consenting to waive the notice period [1] - The meeting was attended by all six directors and was presided over by the chairwoman, Ma Lin [1] Investment Decision - The board approved an investment agreement for capital increase in Suzhou Jicui Intelligent Manufacturing Technology Research Institute Co., Ltd. [2] - The total capital increase is 20 million yuan, with Baoxin Technology subscribing for 18 million yuan and Jiangsu Jicui subscribing for 2 million yuan [1] - Post-investment, Baoxin Technology will hold 81.82% of the target company's shares, Jiangsu Jicui will hold 16.36%, and Lu Zigui will hold 1.82% [1][2] Voting Results - The proposal received unanimous approval with 6 votes in favor, 0 against, and 0 abstentions [2]

证券代码：000929 证券简称：*ST 兰黄 公告编号：2025（临）-63 兰州黄河企业股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈 述或重大遗漏。 一、董事会会议召开情况 黄滔女士、李孔攀先生以通讯表决方式出席会议。 《公司章程》等的相关规定。 二、董事会会议审议情况 与会董事经认真审议，以投票表决的方式形成如下决议： 具体内容详见与本公告同日披露于《中国证券报》《证券时报》和 巨潮资讯网（http://www.cninfo.com.cn）（以下简称"指定信息披露媒体" 十四次会议通知于 2025 年 9 月 3 日以书面、电子通信等方式发出，本次 会议为紧急会议，召集人已对本次紧急会议作出说明，经全体董事一致同 意豁免会议通知期限要求，与会的各位董事已知悉所审议事项相关的必要 信息。 里河区郑家庄 108 号 2 楼会议室以现场结合通讯表决方式召开。 《关于购买股权的公告》（公告编号：2025（临）-64）。 表决结果：同意 9 票、反对 0 票、弃权 0 票。 本议案已经公司第十二届董事会战略委员会第二次会议审议通过， 本议案已经公司第十二届董事会审 ...

证券代码：688639 证券简称：华恒生物 公告编号：2025-034 安徽华恒生物科技股份有限公司 第四届董事会第二十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 安徽华恒生物科技股份有限公司（以下简称"公司"）第四届董事会第二 十三次会议于 2025 年 9 月 4 日在公司会议室以现场结合通讯方式召开。会议 通知已于 2025 年 8 月 25 日以专人递送方式送达全体董事。本次会议应出席董 事 9 名，实际出席董事 9 名。本次会议由董事长郭恒华女士召集并主持。本次 会议的召集和召开程序符合有关法律、行政法规、部门规章、规范性文件和 《公司章程》的规定，会议决议合法、有效。 二、董事会会议审议情况 （一）审议通过《关于公司发行 H 股股票并在香港联合交易所有限公司上 市的议案》 为深入推进公司全球化发展战略，提升品牌影响力与核心竞争力，巩固行 业领先地位，充分借助国际资本市场的资源与机制优势，优化资本结构，拓宽 多元融资渠道，全面提升公司治理水平和综合实力，公司拟发行境外上市 ...

Group 1 - The board of directors of Shida Shenghua New Materials Group Co., Ltd. held its 22nd meeting of the 8th session on September 4, 2025, with all 9 directors present and voting [1][2]. - The board approved the establishment of a calcium chloride project with an annual capacity of 53,000 tons [1][2]. - The board also approved the signing of an investment cooperation agreement by the company's controlling subsidiary [2][3]. Group 2 - The board approved the use of raised funds to replace pre-invested funds in investment projects and to cover previously paid issuance expenses [3]. - The board decided to reappoint Lixin Certified Public Accountants (Special General Partnership) as the auditing firm for the year 2025, based on the audit committee's review [3].

证券代码：603139 证券简称：康惠制药 公告编号：2025-055 陕西康惠制药股份有限公司 第六届董事会第一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 陕西康惠制药股份有限公司（以下简称"公司"）于 2025 年 9 月 4 日召开 会顺利运行，经全体董事同意后，豁免会议通知时间要求，现场决定召开公司第 六届董事会第一次会议。会议应出席董事 9 人，实际参加董事 9 人。本次会议由 全体董事推举的董事李红明先生主持。本次会议符合《公司法》、 《公司章程》和 《董事会议事规则》的有关规定，会议的召集、召开合法有效。 二、董事会会议审议情况 经与会董事审议和表决，通过了以下决议： 本次会议选举李红明先生为公司第六届董事会董事长（公司法定代表人）， 任期三年，自本次董事会审议通过之日起至第六届董事会任期届满之日止。 表决结果：同意 9 票，反对 0 票，弃权 0 票。 本次会议选举第六届董事会各专门委员会委员，任期与第六届董事会一致， 自本次董事会审议通过之日起三年。公司董事会下设战 ...

Group 1 - The board of directors of Huizhou Intelligent Technology Group Co., Ltd. held a meeting on September 2025, which complied with relevant laws and regulations [1][2] - The board approved several proposals with voting results showing unanimous support, including a proposal that requires further approval from the shareholders' meeting [1][2] - The company will hold its first temporary shareholders' meeting of 2025 on September 23, 2025, to discuss the approved proposals [2] Group 2 - The board's voting results for the proposals included 8 votes in favor, 0 abstentions, and 0 votes against for one proposal, and 7 votes in favor, 0 abstentions, and 0 votes against for another, with an associated director abstaining from the vote [1][2] - The proposals included guarantees between subsidiaries and a related transaction regarding the transfer of fund shares, both of which were approved by independent directors [1]

证券代码：605289 证券简称：罗曼股份 公告编号：2025-043 本议案已经独立董事专门会议2025年第三次会议审议通过，并同意提交董 事会审议。 具体内容详见公司同日在上海证券交易所网站（www.sse.com.cn）及指定 媒体上披露的《关于购买资产暨关联交易的公告》（公告编号：2025-042）。 上海罗曼科技股份有限公司 第四届董事会第三十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况： 上海罗曼科技股份有限公司（以下简称"公司"）第四届董事会第三十三 次会议于2025年9月3日以现场结合通讯方式召开。会议通知及会议资料以书面 方式向全体董事发出。本次会议应出席董事9名，实际出席9名。本次会议的召 集和召开符合相关法律法规、《公司法》及《公司章程》的规定。 会议由董事长孙凯君女士主持召开，会议以记名投票表决的方式，审议通 过了如下议案： 二、董事会会议审议情况： 议案》，并提请股东大会审议； 特此公告。 上海罗曼科技股份有限公司 董事会 议案表决情况：同意8票，反对0票， ...

Core Points - The company is holding its third extraordinary general meeting of shareholders on September 12, 2025, to discuss various proposals, including the cancellation of the supervisory board and amendments to the articles of association [2][5][6] - The meeting will utilize a combination of on-site and online voting methods to ensure shareholder participation [2][3] - The proposal to cancel the supervisory board is in line with the revised Company Law of the People's Republic of China and aims to enhance the efficiency of corporate governance [5][6][7] Meeting Agenda - The meeting will commence with the announcement of attendance and reading of the agenda [2] - Shareholders will have the opportunity to speak and ask questions, followed by responses from the board and management [3][4] - Voting will take place after discussions, with results being compiled and announced [2][4] Proposal Details - The proposal to abolish the supervisory board will transfer its responsibilities to the audit committee of the board, ensuring that internal oversight mechanisms remain intact [5][6] - Amendments to the articles of association will include changes in terminology and the adjustment of shareholding thresholds for certain actions [5][7] - The company will also seek authorization from shareholders for the general manager to handle the necessary registration changes following the approval of the proposals [5][6] Legal Compliance - The company emphasizes adherence to the regulations set forth by the China Securities Regulatory Commission and relevant laws during the meeting [3][4] - Legal representatives will be present to ensure compliance and provide legal opinions on the proceedings [4][6]

Summary of Key Points Core Viewpoint - The announcement details the share reduction results of a specific shareholder, Hangsheng Partnership, which has reduced its holdings in Furande Co., Ltd. through block trading and other methods, impacting the overall share structure of the company [1][2]. Group 1: Share Reduction Details - Hangsheng Partnership reduced its holdings by a total of 12,522,380 shares, which accounts for 2.54% of the company's total share capital [2]. - The reduction was executed between May 23, 2025, and September 3, 2025, with a total of 2,665,800 shares sold through centralized bidding and 9,856,580 shares through block trading [2][3]. - The total amount raised from the share reduction was approximately 158.26 million yuan, with share prices ranging from 11.84 to 18.37 yuan per share [2]. Group 2: Current Shareholding Status - After the completion of the reduction plan, Hangsheng Partnership holds 8,044,672 shares, representing 1.63% of the total share capital [2][4]. - Prior to the reduction, Hangsheng Partnership held 20,567,052 shares, which was 4.17% of the total share capital [2][3]. Group 3: Compliance with Reduction Plan - The actual reduction results were consistent with the previously disclosed reduction plan, although the minimum reduction quantity was not set [6]. - The reduction plan was fully implemented, with no early termination of the plan [6].

Meeting Information - The meeting will be held on September 15, 2025, at 14:00, both in-person and online [2] - The in-person meeting location is the conference room 107, Henglin B District Office Building, Anji County, Huzhou City, Zhejiang Province [2] Agenda Items - The shareholders will review the following proposals: 1. Profit distribution plan for the first half of 2025 2. Proposal to abolish and revise certain management systems [3][6] Profit Distribution Plan - The company reported a net profit attributable to shareholders of 181,376,054.07 yuan for the first half of 2025 [6] - The proposed cash dividend is 5.50 yuan per 10 shares, totaling 76,486,867.05 yuan, which accounts for 42.17% of the net profit [6] Management System Revisions - The company plans to abolish the "Supervisory Committee Meeting Rules" and "Authorization Management System" and revise the "Behavior Norms of Controlling Shareholders and Actual Controllers" [7][8] - The new norms aim to enhance the governance structure and protect the rights of minority shareholders [9] Meeting Procedures - The meeting will follow a structured process including proposal reading, discussion, and voting [3][4] - Shareholders must register to speak or ask questions at least 10 minutes before the meeting starts [3] Voting and Decision Announcement - Voting will be conducted via a named voting system, and results will be announced after the meeting [4][5]